Specifically, we showed an inverse association between serum IGF-1 levels and stroke recovery, in agreement with a clinical study [24], highlighting the potential of determining serum IGF-1 levels at hospitalisation (corresponding to the sub-acute post-stroke IGF-1 levels in our study) as a biomarker for stroke outcome. The gene discussed is IGF1; the disease is stroke disorder.